Search research articles
Contact Us
Filters
Showing results (841-850 of 933) with videos related to
Page
of 94
Sort By:
Human Pathology
|
August 20, 2018
High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma
Iris Polifka, Abbas Agaimy, Edwin Herrmann, et al.
The Journal of Urology
|
December 17, 2009
Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review
Edwin Herrmann, Lutz Trojan, Frank Becker, et al.
International Journal of Cancer
|
April 25, 2025
Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?
Christoph Schubart, Lars Tögel, Maria Giulia Carta, et al.
Geburtshilfe Und Frauenheilkunde
|
February 16, 2022
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
Alexander Hein, Sven Kehl, Lothar Häberle, et al.
BJU International
|
April 12, 2018
The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer
Elisabeth E Fransen van de Putte, Judith Bosschieter, Theo H van der Kwast, et al.
Gut
|
October 26, 2023
IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling
Mircea Teodor Chiriac, Zsuzsanna Hracsko, Claudia Günther, et al.
Breast Care (Basel, Switzerland)
|
June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes
Franziska Würfel, Ramona Erber, Hanna Huebner, et al.
EMBO Molecular Medicine
|
November 1, 2014
Molecular profiling of single circulating tumor cells with diagnostic intention
Bernhard Polzer, Gianni Medoro, Sophie Pasch, et al.
Pathology, Research and Practice
|
February 18, 2022
The prognostic impact of Claudin 6 in papillary renal cell carcinoma
Marie Mikuteit, Stefanie Zschäbitz, Christine Stöhr, et al.
International Journal of Molecular Sciences
|
August 12, 2022
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting
Ramona Erber, Miriam Angeloni, Robert Stöhr, et al.
Page
of 94
Search research articles
Search
Showing results (841-850 of 933) with videos related to
Sort By:
Page
of 94
Human Pathology
|
August 20, 2018
High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma
Iris Polifka, Abbas Agaimy, Edwin Herrmann, et al.
The Journal of Urology
|
December 17, 2009
Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review
Edwin Herrmann, Lutz Trojan, Frank Becker, et al.
International Journal of Cancer
|
April 25, 2025
Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?
Christoph Schubart, Lars Tögel, Maria Giulia Carta, et al.
Geburtshilfe Und Frauenheilkunde
|
February 16, 2022
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
Alexander Hein, Sven Kehl, Lothar Häberle, et al.
BJU International
|
April 12, 2018
The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer
Elisabeth E Fransen van de Putte, Judith Bosschieter, Theo H van der Kwast, et al.
Gut
|
October 26, 2023
IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling
Mircea Teodor Chiriac, Zsuzsanna Hracsko, Claudia Günther, et al.
Breast Care (Basel, Switzerland)
|
June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes
Franziska Würfel, Ramona Erber, Hanna Huebner, et al.
EMBO Molecular Medicine
|
November 1, 2014
Molecular profiling of single circulating tumor cells with diagnostic intention
Bernhard Polzer, Gianni Medoro, Sophie Pasch, et al.
Pathology, Research and Practice
|
February 18, 2022
The prognostic impact of Claudin 6 in papillary renal cell carcinoma
Marie Mikuteit, Stefanie Zschäbitz, Christine Stöhr, et al.
International Journal of Molecular Sciences
|
August 12, 2022
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting
Ramona Erber, Miriam Angeloni, Robert Stöhr, et al.
Page
of 94